Feng-Xu Wu
Frontiers in Chemistry · 2020
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Feng-Xu Wu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Feng-Xu Wu's perspective
Ordered by how strongly the researchers Feng-Xu Wu trusts endorse each paper. Same corpus, a different order for every researcher.
- DrugBank: a comprehensive resource for in silico drug discovery and exploration
- admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties (Journal of Chemical Information and Modeling)
- DrugBank 4.0: shedding new light on drug metabolism
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures (Journal of Medicinal Chemistry)
- Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
- PubChem 2019 update: improved access to chemical data (Nucleic Acids Res.)
- ADME evaluation in drug discovery (Journal of Molecular Modeling)
- Physiologically-based pharmacokinetics in drug development and regulatory science. (Annual Review of Pharmacology and Toxicology)
- DrugBank 5.0: a major update to the DrugBank database for 2018 (Nucleic Acids Res.)
- The Comparative Toxicogenomics Database: update 2019 (Nucleic Acids Res.)
Their papers
- Computational Approaches in Preclinical Studies on Drug Discovery and Development (2020) — 355 citations